Fisher expands in diagnostics | Chemical & Engineering News
Volume 84 Issue 12 | p. 21 | Concentrates
Issue Date: March 20, 2006

Fisher expands in diagnostics

Department: Business

Fisher Scientific has entered a definitive agreement to acquire privately held Athena Diagnostics, a developer of neurologic, nephrologic, and endocrine diagnostic tests, from Behrman Capital for $283 million. Fisher also agreed to buy a 9% stake in Nanogen, a manufacturer of diagnostic equipment, microarrays, and reagents, for $15 million. Fisher says it will collaborate with Nanogen to develop Athena's proprietary markers and diagnostic assays.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment